Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(7): 020-026


Preparation of a Doxorubicin Conjugate with (Co) Polymers of Methacrylic acid for Targeted Tumor Therapy

Olga Zhukova, Svetlana Bulgakova.




Abstract

Abstract. Objective: This study was performed in order to creation of a doxorubicin conjugate with methacrylic acid (co)polymers for targeted tumor therapy.
Methods and materials: Results: Poly(t-butylmethacrylate) with the optimal for biocompatible polymers molecular-weight characteristics (Mn= 12,400; Mw/Mn = 1.35) was synthesized by radical polymerization in the presence of thioglycolic acid as a chain transfer agent. The obtained polymer was converted by acid hydrolysis into a water-soluble copolymer of t-butylmethacrylate and methacrylic acid of 20:80 mass%, respectively. The copolymer of t-butylmethacrylate and methacrylic acid was modified with folic acid which has affinity for tumor cells. A conjugate of the copolymer with doxorubicin and also a conjugate with the folate vector were synthesized. Their formation was proved using elemental analysis and IR, UV, NMR spectroscopy.
Conclusion: Thus, in the course of the study the conjugate of doxorubicin was synthesized, combining the drug and a vector for delivery of the drug. This compound is a promising, as it represents a new form of transport delivering a well-known and widely used anticancer agent doxorubicin.

Key words: Keywords: polymeric drug carrier, copolymer of methacrylic acid and t-butylmethacrylate, doxorubicin, folate vector, UV-spectroscopy, IR-spectroscopy, NMR-spectroscopy.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.